Cost-savings associated with Warfarin use in AFib patients
Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.
Mercaldi, CJ, M Ciaramentaro, B Hahn, G Chalissery, MW Reynolds, SD Sander, GP Samsa, and DB Matchar. Cost Efficiency of Anticoagulation with Warfarin to Prevent Stroke in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation. Stroke. 2011; 42(1): 112-8. http://stroke.ahajournals.org/cgi/content/short/42/1/112